作者：
Francesca,Chemi [1]
;
Dominic G,Rothwell [2]
;
Nicholas,McGranahan [1]
;
Sakshi,Gulati [3]
;
Chris,Abbosh [4]
;
Simon P,Pearce [5]
;
Cong,Zhou [1]
;
Gareth A,Wilson [4]
;
Mariam,Jamal-Hanjani [1]
;
Nicolai,Birkbak [1]
;
Jackie,Pierce [4]
;
Chang Sik,Kim [5]
;
Saba,Ferdous [3]
;
Deborah J,Burt [4]
;
Daniel,Slane-Tan [4]
;
Fabio,Gomes [5]
;
David,Moore [6]
;
Rajesh,Shah [1]
;
Maise,Al Bakir [1]
;
Crispin,Hiley [1]
;
Selvaraju,Veeriah [1]
;
Yvonne,Summers [1]
;
Philip,Crosbie [2]
;
Sophia,Ward [4]
;
Barbara,Mesquita [7]
;
Marek,Dynowski [5]
;
Dhruva,Biswas [3]
;
Jonathan,Tugwood [4]
;
Fiona,Blackhall [4]
;
Crispin,Miller [8]
;
Allan,Hackshaw [2]
;
Ged,Brady [8]
;
Charles,Swanton [9]
;
Caroline,Dive [5]
;
TRACERx Consortium [1]
作者单位：
Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
[1]
Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK.
[2]
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
[3]
University College London Cancer Institute, London, UK.
[4]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
[5]
Department of Molecular Medicine, Aarhus University, Aarhus, Denmark.
[6]
Department of Thoracic Surgery, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
[7]
Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
[8]
North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
[9]
Scientific Computing Core Facility, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
[10]
RNA Biology, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK.
[11]
Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK. ged.brady@cruk.manchester.ac.uk.
[12]
Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
[13]
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.
[14]
University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.
[15]
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.
[16]
Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, UK. caroline.dive@cruk.manchester.ac.uk.
[17]
Cancer Research UK Lung Cancer Centre of Excellence, The University of Manchester, Manchester, UK. caroline.dive@cruk.manchester.ac.uk.
[18]
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);基因组, 人(Genome, Human);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);肿瘤细胞, 循环(Neoplastic Cells, Circulating);肺静脉(Pulmonary Veins)
DOI
10.1038/s41591-019-0593-1
PMID
31591595
发布时间
2024-02-16
换一批
换一批
